Cargando…

Potential Inhibitory Effect of Apis mellifera’s Venom and of Its Two Main Components—Melittin and PLA(2)—on Escherichia coli F(1)F(0)-ATPase

Bacterial resistance has become a worrying problem for human health, especially since certain bacterial strains of Escherichia coli (E. coli) can cause very serious infections. Thus, the search for novel natural inhibitors with new bacterial targets would be crucial to overcome resistance to antibio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nehme, Hala, Ayde, Helena, El Obeid, Dany, Sabatier, Jean Marc, Fajloun, Ziad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699247/
https://www.ncbi.nlm.nih.gov/pubmed/33218209
http://dx.doi.org/10.3390/antibiotics9110824
_version_ 1783616005611716608
author Nehme, Hala
Ayde, Helena
El Obeid, Dany
Sabatier, Jean Marc
Fajloun, Ziad
author_facet Nehme, Hala
Ayde, Helena
El Obeid, Dany
Sabatier, Jean Marc
Fajloun, Ziad
author_sort Nehme, Hala
collection PubMed
description Bacterial resistance has become a worrying problem for human health, especially since certain bacterial strains of Escherichia coli (E. coli) can cause very serious infections. Thus, the search for novel natural inhibitors with new bacterial targets would be crucial to overcome resistance to antibiotics. Here, we evaluate the inhibitory effects of Apis mellifera bee venom (BV-Am) and of its two main components -melittin and phospholipase A(2) (PLA(2))- on E. coli F(1)F(0)-ATPase enzyme, a crucial molecular target for the survival of these bacteria. Thus, we optimized a spectrophotometric method to evaluate the enzymatic activity by quantifying the released phosphate from ATP hydrolysis catalyzed by E. coli F(1)F(0)-ATPase. The protocol developed for inhibition assays of this enzyme was validated by two reference inhibitors, thymoquinone (IC(50) = 57.5 μM) and quercetin (IC(50) = 30 μM). Results showed that BV-Am has a dose-dependent inhibitory effect on E. coli F(1)F(0)-ATPase with 50% inhibition at 18.43 ± 0.92 μg/mL. Melittin inhibits this enzyme with IC(50) = 9.03 ± 0.27 µM, emphasizing a more inhibitory effect than the two previous reference inhibitors adopted. Likewise, PLA(2) inhibits E. coli F(1)F(0)-ATPase with a dose-dependent effect (50% inhibition at 2.11 ± 0.11 μg/mL) and its combination with melittin enhanced the inhibition extent of this enzyme. Crude venom and mainly melittin and PLA(2), inhibit E. coli F(1)F(0)-ATPase and could be considered as important candidates for combating resistant bacteria.
format Online
Article
Text
id pubmed-7699247
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76992472020-11-29 Potential Inhibitory Effect of Apis mellifera’s Venom and of Its Two Main Components—Melittin and PLA(2)—on Escherichia coli F(1)F(0)-ATPase Nehme, Hala Ayde, Helena El Obeid, Dany Sabatier, Jean Marc Fajloun, Ziad Antibiotics (Basel) Article Bacterial resistance has become a worrying problem for human health, especially since certain bacterial strains of Escherichia coli (E. coli) can cause very serious infections. Thus, the search for novel natural inhibitors with new bacterial targets would be crucial to overcome resistance to antibiotics. Here, we evaluate the inhibitory effects of Apis mellifera bee venom (BV-Am) and of its two main components -melittin and phospholipase A(2) (PLA(2))- on E. coli F(1)F(0)-ATPase enzyme, a crucial molecular target for the survival of these bacteria. Thus, we optimized a spectrophotometric method to evaluate the enzymatic activity by quantifying the released phosphate from ATP hydrolysis catalyzed by E. coli F(1)F(0)-ATPase. The protocol developed for inhibition assays of this enzyme was validated by two reference inhibitors, thymoquinone (IC(50) = 57.5 μM) and quercetin (IC(50) = 30 μM). Results showed that BV-Am has a dose-dependent inhibitory effect on E. coli F(1)F(0)-ATPase with 50% inhibition at 18.43 ± 0.92 μg/mL. Melittin inhibits this enzyme with IC(50) = 9.03 ± 0.27 µM, emphasizing a more inhibitory effect than the two previous reference inhibitors adopted. Likewise, PLA(2) inhibits E. coli F(1)F(0)-ATPase with a dose-dependent effect (50% inhibition at 2.11 ± 0.11 μg/mL) and its combination with melittin enhanced the inhibition extent of this enzyme. Crude venom and mainly melittin and PLA(2), inhibit E. coli F(1)F(0)-ATPase and could be considered as important candidates for combating resistant bacteria. MDPI 2020-11-18 /pmc/articles/PMC7699247/ /pubmed/33218209 http://dx.doi.org/10.3390/antibiotics9110824 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nehme, Hala
Ayde, Helena
El Obeid, Dany
Sabatier, Jean Marc
Fajloun, Ziad
Potential Inhibitory Effect of Apis mellifera’s Venom and of Its Two Main Components—Melittin and PLA(2)—on Escherichia coli F(1)F(0)-ATPase
title Potential Inhibitory Effect of Apis mellifera’s Venom and of Its Two Main Components—Melittin and PLA(2)—on Escherichia coli F(1)F(0)-ATPase
title_full Potential Inhibitory Effect of Apis mellifera’s Venom and of Its Two Main Components—Melittin and PLA(2)—on Escherichia coli F(1)F(0)-ATPase
title_fullStr Potential Inhibitory Effect of Apis mellifera’s Venom and of Its Two Main Components—Melittin and PLA(2)—on Escherichia coli F(1)F(0)-ATPase
title_full_unstemmed Potential Inhibitory Effect of Apis mellifera’s Venom and of Its Two Main Components—Melittin and PLA(2)—on Escherichia coli F(1)F(0)-ATPase
title_short Potential Inhibitory Effect of Apis mellifera’s Venom and of Its Two Main Components—Melittin and PLA(2)—on Escherichia coli F(1)F(0)-ATPase
title_sort potential inhibitory effect of apis mellifera’s venom and of its two main components—melittin and pla(2)—on escherichia coli f(1)f(0)-atpase
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699247/
https://www.ncbi.nlm.nih.gov/pubmed/33218209
http://dx.doi.org/10.3390/antibiotics9110824
work_keys_str_mv AT nehmehala potentialinhibitoryeffectofapismelliferasvenomandofitstwomaincomponentsmelittinandpla2onescherichiacolif1f0atpase
AT aydehelena potentialinhibitoryeffectofapismelliferasvenomandofitstwomaincomponentsmelittinandpla2onescherichiacolif1f0atpase
AT elobeiddany potentialinhibitoryeffectofapismelliferasvenomandofitstwomaincomponentsmelittinandpla2onescherichiacolif1f0atpase
AT sabatierjeanmarc potentialinhibitoryeffectofapismelliferasvenomandofitstwomaincomponentsmelittinandpla2onescherichiacolif1f0atpase
AT fajlounziad potentialinhibitoryeffectofapismelliferasvenomandofitstwomaincomponentsmelittinandpla2onescherichiacolif1f0atpase